Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Overview
This workshop will be conducted in Japanese Language only.
View the Program in Japanese
Featured topics
The Flyer of the Chatting Session is here.
Program Committee
-
Kentaro Kogushi, PhD • Head of Clinical Development, Japan Development
AbbVie GK, Japan -
Toshihiko Aranishi, PhD • Research Scientist, Health Outcomes/Health Technology Assessment
Eli Lilly Japan K.K, Japan -
Mariko Hirozane, PhD • Associate director, Policy intelligence department, Integrated Market Access Div
Janssen Pharmaceutical K.K. , Japan -
Shinya Ohno, PhD, MPH • Director, HTA Strategy Professional
Chugai Pharmaceutical Co., Ltd, Japan -
Akihito Uda, MPH • HEOR Group, Market Access and Public Affairs Division
Novartis Pharma K.K., Japan -
Hisashi Urushihara, DrPH • Professor, Faculty of Pharmacy
Keio University, Japan -
Kentaro Yamato, RPh • Head of HEOR/RWE, Medical Affairs
Otsuka Pharmaceutical Co., Ltd., Japan -
Keisuke Yoshihara, PhD, MSc • HEOR Research Associate
Bayer Yakuhin, Ltd., Japan -
Manami Yoshida, DVM • Manager, Global Medical Affairs
Shionogi & Co., Ltd., Japan -
Shinzo Hiroi, PhD, MPH, RPh, PMP • Head of Global Medical Affairs
Shionogi & Co., Ltd., Japan -
Yuta Kasai • Japan-Asia Clinical Development 2
Astellas Pharma Inc, Japan -
Akiko Nishioka • Clinical Research Associate, Clinical Operation
Novartis Pharma K.K., Japan
